Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Immuneering Corp as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +4 vs. Q3 2024
- Shares held
- 4.30M
- −52.9K (−1.2%) vs. Q3 2024
- Total value
- $9.32M
- −$1.55M (−14.2%) vs. Q3 2024
- New holders
- 7
- 12 more added
- Sold out
- 3
- 10 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $171.6M |
| Q1 2026 | 96 | $154.3M |
| Q4 2025 | 85 | $208.6M |
| Q3 2025 | 69 | $183.3M |
| Q2 2025 | 39 | $12.9M |
| Q1 2025 | 35 | $6.84M |
| Q4 2024 | 42 | $9.32M |
| Q3 2024 | 38 | $10.9M |
| Q2 2024 | 59 | $12.3M |
| Q1 2024 | 51 | $34.3M |
| Q4 2023 | 52 | $118.6M |
| Q3 2023 | 52 | $130.1M |
| Q2 2023 | 49 | $175.9M |
| Q1 2023 | 35 | $114.9M |
| Q4 2022 | 34 | $56.9M |
| Q3 2022 | 32 | $172.5M |
| Q2 2022 | 37 | $65.7M |
| Q1 2022 | 50 | $88.1M |
| Q4 2021 | 37 | $200.1M |
| Q3 2021 | 38 | $316.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Immuneering Corp; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,056,922 | $2.33M | 0.00% | −13,400−1.3% | Reduced |
| Price T Rowe Associates Inc | 767,124 | $1.69M | 0.00% | −43,003−5.3% | Reduced |
| Morgan Stanley | 454,100 | $999.0K | 0.00% | +4,789+1.1% | Added |
| BlackRock, Inc. | 318,763 | $701.3K | 0.00% | +344+0.1% | Added |
| Southport Management, L.L.C. | 215,000 | $473.0K | 1.71% | +10,000+4.9% | Added |
| Geode Capital Management, LLC | 208,387 | $458.6K | 0.00% | −1,254−0.6% | Reduced |
| Rockefeller Capital Management L.P. | 177,377 | $390.2K | 0.00% | +177,377 | New |
| TD Asset Management Inc | 150,876 | $331.9K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 102,936 | $226.5K | 0.00% | −143,334−58.2% | Reduced |
| Manufacturers Life Insurance Company, The | 82,638 | $181.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 78,535 | $172.8K | 0.00% | +9,300+13.4% | Added |
| HighTower Advisors, LLC | 71,360 | $157.0K | 0.00% | +18,000+33.7% | Added |
| Exchange Traded Concepts, LLC | 58,349 | $128.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 52,493 | $115.5K | 0.00% | +20,948+66.4% | Added |
| Bridgeway Capital Management, LLC | 51,349 | $113.0K | 0.00% | +22,400+77.4% | Added |
| Two Sigma Investments, LP | 50,557 | $111.2K | 0.00% | +10,126+25.0% | Added |
| Tidemark, LLC | 44,400 | $97.7K | 0.04% | −7,450−14.4% | Reduced |
| Northern Trust Corp | 39,729 | $87.4K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 32,650 | $71.8K | 0.01% | +20,871+177.2% | Added |
| First Manhattan Co | 32,325 | $71.1K | 0.00% | +32,325 | New |
| Bank of America Corp | 31,054 | $68.3K | 0.00% | −333−1.1% | Reduced |
| Marshall Wace, LLP | 21,432 | $47.1K | 0.00% | +21,432 | New |
| The PNC Financial Services Group, Inc. | 20,000 | $44.0K | 0.00% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 17,421 | $38.3K | 0.01% | −403−2.3% | Reduced |
| Man Group plc | 13,914 | $30.6K | 0.00% | +136+1.0% | Added |
| Dimensional Fund Advisors LP | 13,366 | $29.4K | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 12,073 | $26.6K | 0.00% | +12,073 | New |
| JustInvest LLC | 11,705 | $25.8K | 0.00% | +11,705 | New |
| Vontobel Holding Ltd. | 10,000 | $22.4K | 0.00% | 00.0% | Unchanged |
| Corsair Capital Management, L.P. | 10,000 | $22.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 9,924 | $21.8K | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 10,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,838 | $8.44K | 0.00% | −1,297−25.3% | Reduced |
| Tower Research Capital LLC (TRC) | 2,400 | $5.28K | 0.00% | +432+22.0% | Added |
| Citigroup Inc | 2,297 | $5.05K | 0.00% | +1,501+188.6% | Added |
| JPMorgan Chase & Co | 1,974 | $4.34K | 0.00% | −450−18.6% | Reduced |
| Cubist Systematic Strategies, LLC | 659 | $1.45K | 0.00% | −1−0.2% | Reduced |
| BNP Paribas Arbitrage, SA | 349 | $768 | 0.00% | +349 | New |
| EverSource Wealth Advisors, LLC | 345 | $759 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 74 | $163 | 0.00% | +74 | New |
| CI Private Wealth, LLC | 63,740 | $140 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 16 | $35 | 0.00% | 00.0% | Unchanged |
| Prosight Management, LP | 0 | $0 | 0.00% | −190,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,823−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −11,294−100.0% | Sold out |